SIM
HBIO icon

Spark Investment Management’s Harvard Bioscience HBIO Stock Holding History

Spark Investment Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,320
Closed -$143K – 627
2019
Q1 		$143K Hold
3,320
– – 0.01% 540
2018
Q4 		$105K Buy
3,320
+910
+38% +$35.9K 0.01% 554
2018
Q3 		$126K Sell
2,410
-900
-27% -$50.5K 0.01% 595
2018
Q2 		$177K Sell
3,310
-900
-21% -$46.1K 0.01% 568
2018
Q1 		$210K Sell
4,210
-1,860
-31% -$83.4K 0.01% 501
2017
Q4 		$200K Sell
6,070
-890
-13% -$30K 0.01% 574
2017
Q3 		$261K Sell
6,960
-3,760
-35% -$111K 0.01% 572
2017
Q2 		$273K Sell
10,720
-975
-8% -$24.1K 0.02% 600
2017
Q1 		$304K Buy
11,695
+1,325
+13% +$38.2K 0.02% 636
2016
Q4 		$316K Buy
10,370
+20
+0.2% +$509 0.03% 564
2016
Q3 		$281K Buy
10,350
+6,850
+196% +$190K 0.02% 596
2016
Q2 		$100K Buy
3,500
+1,650
+89% +$52.5K 0.01% 700
2016
Q1 		$55K Buy
1,850
+160
+9% +$4.54K 0.01% 738
2015
Q4 		$58K Buy
+1,690
New +$57.8K 0.01% 701
2015
Q3 		– Sell
-3,790
Closed -$215K – 703
2015
Q2 		$215K Hold
3,790
– – 0.03% 507
2015
Q1 		$216K Buy
3,790
+170
+5% +$9.13K 0.03% 538
2014
Q4 		$203K Sell
3,620
-390
-10% -$18.6K 0.03% 493
2014
Q3 		$163K Buy
4,010
+720
+22% +$33.1K 0.02% 539
2014
Q2 		$149K Sell
3,290
-910
-22% -$38.2K 0.02% 527
2014
Q1 		$198K Hold
4,200
– – 0.03% 530
2013
Q4 		$196K Sell
4,200
-2,870
-41% -$125K 0.03% 504
2013
Q3 		$281K Sell
7,070
-633
-8% -$24.9K 0.06% 385
2013
Q2 		$273K Buy
+7,703
New +$295K 0.07% 310

Other funds holding HBIO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Spark Investment Management's HBIO Position: Q2 2019 in Review

Spark Investment Management sold out of Harvard Bioscience (HBIO) in Q2 2019, closing a stake of 3,320 shares — an estimated $143K sold.

Spark Investment Management first reported a position in HBIO in Q2 2013 and held it in 23 quarters. The position peaked at $316K in Q4 2016. 78 funds tracked by Wall St. Rank hold HBIO as of Q2 2019.

  • Spark Investment Management reported no remaining Harvard Bioscience position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 3,320 Harvard Bioscience shares in Q2 2019, an estimated $143K.
  • Spark Investment Management first reported a position in Harvard Bioscience in Q2 2013 and held it in 23 quarters.
  • Spark Investment Management's Harvard Bioscience position peaked at $316K in Q4 2016.
  • 78 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.